Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biotechnol Prog ; 34(3): 584-592, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-28960825

RESUMEN

In the development of biopharmaceutical products, the expectation of regulatory agencies is that the recombinant proteins are produced from a cell line derived from a single progenitor cell. A single limiting dilution step followed by direct imaging, as supplemental information, provides direct evidence that a cell line originated from a single progenitor cell. To obtain this evidence, a high-throughput automated imaging system was developed and characterized to consistently ensure that cell lines used for therapeutic protein production are clonally-derived. Fluorescent cell mixing studies determined that the automated imaging workflow and analysis provide ∼95% confidence in accurately and precisely identifying one cell in a well. Manual inspection of the images increases the confidence that the cell line was derived from a single-cell to >99.9%. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 34:584-592, 2018.


Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Automatización , Técnicas de Cultivo de Célula , Células Clonales/citología , Células Clonales/metabolismo , Procesamiento de Imagen Asistido por Computador , Proteínas Recombinantes/biosíntesis , Animales , Anticuerpos Monoclonales/uso terapéutico , Células CHO , Cricetulus , Ensayos Analíticos de Alto Rendimiento , Proteínas Recombinantes/uso terapéutico
2.
Metab Eng ; 43(Pt B): 218-225, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28122259

RESUMEN

Industrial bioprocesses place high demands on the energy metabolism of host cells to meet biosynthetic requirements for maximal protein expression. Identifying metabolic phenotypes that promote high expression is therefore a major goal of the biotech industry. We conducted a series of 13C flux analysis studies to examine the metabolic response to IgG expression during early stationary phase of CHO cell cultures grown in 3L fed-batch bioreactors. We examined eight clones expressing four different IgGs and compared with three non-expressing host-cell controls. Some clones were genetically manipulated to be apoptosis-resistant by expressing Bcl-2Δ, which correlated with increased IgG production and elevated glucose metabolism. The metabolic phenotypes of the non-expressing, IgG-expressing, and Bcl-2Δ/IgG-expressing clones were fully segregated by hierarchical clustering analysis. Lactate consumption and citric acid cycle fluxes were most strongly associated with specific IgG productivity. These studies indicate that enhanced oxidative metabolism is a characteristic of high-producing CHO cell lines.


Asunto(s)
Anticuerpos Monoclonales/biosíntesis , Isótopos de Carbono/química , Ciclo del Ácido Cítrico , Expresión Génica , Inmunoglobulina G/biosíntesis , Marcaje Isotópico , Animales , Anticuerpos Monoclonales/genética , Células CHO , Cricetulus , Inmunoglobulina G/genética , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/genética
3.
Curr Opin Biotechnol ; 30: 147-52, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25032906

RESUMEN

Terminal sialic acid residues of glycoconjugates exhibit remarkable functional and structural diversity. They affect biological activity, serum half-life and structural stability of glycoproteins. Alternatively, they act as mediators for pathogens to invade host systems. These surface exposed N-glycans are easily accessible for interactions with receptors, enzymes, etc. In contrast, Fc N-glycans of IgGs are sequestered within the two CH2 domains and exhibit high degree of heterogeneity. They are required for antibody effector functions including binding to C1q protein. Biological significance of Fc glycans has been extensively studied and importance of terminal galactose, bisecting GlcNAc and core fucose has been realized. This review focuses on the recent advances in structure and functions of terminal sialic acid residues of Fc glycans.


Asunto(s)
Fragmentos Fc de Inmunoglobulinas/metabolismo , Ácido N-Acetilneuramínico/metabolismo , Animales , Anticuerpos/química , Anticuerpos/metabolismo , Glicoproteínas/metabolismo , Glicosilación , Humanos , Fragmentos Fc de Inmunoglobulinas/química , Ácido N-Acetilneuramínico/análogos & derivados , Polisacáridos/química
4.
Metab Eng ; 25: 92-102, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25014175

RESUMEN

Anti-apoptosis engineering is an established technique to prolong the viability of mammalian cell cultures used for industrial production of recombinant proteins. However, the effect of overexpressing anti-apoptotic proteins on central carbon metabolism has not been systematically studied. We transfected CHO-S cells to express Bcl-2∆, an engineered anti-apoptotic gene, and selected clones that differed in their Bcl-2∆ expression and caspase activity. (13)C metabolic flux analysis (MFA) was then applied to elucidate the metabolic alterations induced by Bcl-2∆. Expression of Bcl-2Δ reduced lactate accumulation by redirecting the fate of intracellular pyruvate toward mitochondrial oxidation during the lactate-producing phase, and it significantly increased lactate re-uptake during the lactate-consuming phase. This flux redistribution was associated with significant increases in biomass yield, peak viable cell density (VCD), and integrated VCD. Additionally, Bcl-2∆ expression was associated with significant increases in isocitrate dehydrogenase and NADH oxidase activities, both rate-controlling mitochondrial enzymes. This is the first comprehensive (13)C MFA study to demonstrate that expression of anti-apoptotic genes has a significant impact on intracellular metabolic fluxes, especially in controlling the fate of pyruvate carbon, which has important biotechnology applications for reducing lactate accumulation and enhancing productivity in mammalian cell cultures.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/metabolismo , Ácido Láctico/metabolismo , Análisis de Flujos Metabólicos/métodos , Proteínas Mitocondriales/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ácido Pirúvico/metabolismo , Transducción de Señal/fisiología , Animales , Proteínas Reguladoras de la Apoptosis/genética , Células CHO , Cricetinae , Cricetulus , Proteínas Mitocondriales/genética , Proteínas Proto-Oncogénicas c-bcl-2/genética
5.
J Biol Chem ; 279(27): 27845-8, 2004 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-15133031

RESUMEN

FK506-binding protein 52 (FKBP52) is an immunophilin that possesses peptidylprolyl cis/trans-isomerase (PPIase) activity and is a component of a subclass of steroid hormone receptor complexes. Several recent studies indicate that immunophilins can regulate neuronal survival and nerve regeneration although the molecular mechanisms are poorly understood. To investigate the function of FKBP52 in the nervous system, we employed a yeast two-hybrid strategy using the PPIase domain (domain I) as bait to screen a neonatal rat dorsal root ganglia cDNA expression library. We identified an interaction between FKBP52 domain I and Atox1, a copper-binding metallochaperone. Atox1 interacts with Menkes disease protein and Wilson disease protein (WD) and functions in copper efflux. The interaction between FKBP52 and Atox1 was observed in both glutathione S-transferase pull-down experiments and when proteins were ectopically expressed in human embryonic kidney (HEK) 293T cells and was sensitive to FK506. Interestingly, the FKBP52/Atox1 interaction was enhanced when HEK 293T cells were cultured in copper-supplemented medium and decreased in the presence of the copper chelator, bathocuproine disulfate, suggesting that the interaction is regulated in part by intracellular copper. Overexpression of FKBP52 increased rapid copper efflux in (64)Cu-loaded cells, as did the overexpression of WD transporter. Taken together, our present findings suggest that FKBP52 is a component of the copper efflux machinery, and in so, may also promote neuroprotection from copper toxicity.


Asunto(s)
Cobre/metabolismo , Inmunofilinas/metabolismo , Proteínas de Unión a Tacrolimus/fisiología , Animales , Transporte Biológico , Western Blotting , Calcio/metabolismo , Línea Celular , Supervivencia Celular , Quelantes/farmacología , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Biblioteca de Genes , Vectores Genéticos , Glutatión Transferasa/metabolismo , Humanos , Cinética , Modelos Genéticos , Neuronas/metabolismo , Fenantrolinas/farmacología , Pruebas de Precipitina , Estructura Terciaria de Proteína , Ratas , Factores de Tiempo , Técnicas del Sistema de Dos Híbridos
6.
Oncogene ; 22(18): 2836-41, 2003 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-12743606

RESUMEN

The adenovirus E1A oncoprotein stimulates cell growth and inhibits differentiation by deregulating the normal transcription program via interaction with positive and negative cellular effectors. E1A associates with transcriptional regulatory complexes containing p400 and TRRAP involved in chromatin remodeling and decondensation. TRRAP is a component of three distinct human histone acetyltransferase (HAT) complexes: the TIP60 complex and complexes containing GCN5 or PCAF. We demonstrate here that E1A binds a TRRAP complex that contains the GCN5 acetyltransferase during a normal adenovirus infection. E1A binds GCN5 and TRRAP in vivo early after virus infection. E1A is associated with significant HAT activity in vitro that is partly attributable to GCN5. E1A represses c-Myc- and E2F-1-directed transcriptional activation in vivo by sequestering GCN5 and/or TRRAP. Our results demonstrate that E1A distinctly binds TRRAP/GCN5, p300/CBP and PCAF HAT complexes. Through interactions with multiple HAT complexes, E1A may deregulate cellular transcription programs and facilitate infection by recruiting functional HAT coactivators to viral and cellular promoter regions.


Asunto(s)
Proteínas E1A de Adenovirus/metabolismo , Proteínas Nucleares/genética , Transactivadores/genética , Proteínas Adaptadoras Transductoras de Señales , Proteínas E1A de Adenovirus/química , Animales , Proteínas de Ciclo Celular , Clonación Molecular , Secuencia Conservada , Histona Acetiltransferasas , Humanos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Factores de Transcripción p300-CBP
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...